KK
JANX icon

KLP Kapitalforvaltning’s Janux Therapeutics JANX Stock Holding History

KLP Kapitalforvaltning’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Hold
10,100
– – ﹤0.01% 1980
2026
Q1 		$140K Buy
10,100
+1,700
+20% +$23.3K ﹤0.01% 1952
2025
Q4 		$116K Hold
8,400
– – ﹤0.01% 2032
2025
Q3 		$205K Hold
8,400
– – ﹤0.01% 1818
2025
Q2 		$194K Hold
8,400
– – ﹤0.01% 1801
2025
Q1 		$227K Hold
8,400
– – ﹤0.01% 1694
2024
Q4 		$450K Buy
+8,400
New +$444K ﹤0.01% 1438

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

KLP Kapitalforvaltning's JANX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Janux Therapeutics (JANX) position steady in Q2 2026 at 10,100 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

KLP Kapitalforvaltning first reported a position in JANX in Q4 2024 and has held it in 7 quarters since. The position peaked at $450K in Q4 2024. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • KLP Kapitalforvaltning held 10,100 shares of Janux Therapeutics worth $155K as of Q2 2026.
  • KLP Kapitalforvaltning left its Janux Therapeutics share count unchanged in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1980 holding.
  • KLP Kapitalforvaltning first reported a position in Janux Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Janux Therapeutics position peaked at $450K in Q4 2024.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.